Related Experiment Videos
Neurologic complications of leukemia
Alexis Demopoulos1, Lisa M DeAngelis
1Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Current Opinion in Neurology
|November 26, 2002
Summary
Improved leukemia treatments lead to longer survival, necessitating better management of neurologic complications. Early diagnosis and treatment of nervous system involvement and neurotoxic therapies are crucial for better patient outcomes.
Area of Science:
- Hematology
- Neurology
- Oncology
Background:
- Leukemia survival rates are increasing due to advancements in treatment.
- Longer survival necessitates addressing long-term complications, particularly neurologic issues.
- Neurologic dysfunction in leukemia patients can stem from direct infiltration or treatment side effects.
Purpose of the Study:
- To review common neurologic complications in leukemia patients.
- To discuss recent diagnostic and therapeutic advancements for these complications.
- To provide insights for improved clinical management.
Main Methods:
- Literature review focusing on neurologic complications of leukemia.
- Synthesis of information on central nervous system prophylaxis.
- Analysis of data regarding leptomeningeal metastasis and brain involvement.
Main Results:
- Neurologic dysfunction arises from leukemic infiltration or treatment toxicity (chemotherapy, irradiation).
- Effective management strategies are available for central nervous system prophylaxis and leptomeningeal metastasis.
- Recognizing and treating these complications improves patient outcomes and reduces long-term sequelae.
Conclusions:
- Timely recognition and treatment of neurologic complications are vital for leukemia patients.
- Advancements in diagnosis and treatment enhance patient survival and quality of life.
- This review offers guidance for clinicians managing neurologic aspects of leukemia.